Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Supernus Pharmaceuticals Inc shares valued at $511,677 were sold by Bhatt Padmanabh P. on Mar 21 ’24. At $35.31 per share, Bhatt Padmanabh P. sold 14,491 shares. The insider’s holdings dropped to 8,570 shares worth approximately $0.24 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Bhatt Padmanabh P. sold 400 shares, netting a total of over 14,124 in proceeds. Following the sale of shares at $35.31 each, the insider now holds 8,570 shares.
Before that, Bhatt Padmanabh P. had sold 12,364 shares from its account. In a trade valued at $436,573, the Sr. VP of IP, CSO traded Supernus Pharmaceuticals Inc shares for $35.31 each. Upon closing the transaction, the insider’s holdings decreased to 12,364 shares, worth approximately $0.24 million.
As of April 13, 2021, Jefferies has increased its “Hold” rating to a “Buy” for SUPN. Earlier on June 16, 2020, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for SUPN stock which previously was a “a Neutral”.
Analyzing SUPN Stock Performance
During the last five days, there has been a drop of approximately -4.77%. Over the course of the year, Supernus Pharmaceuticals Inc shares have dropped approximately -4.04%. Shares of the company reached a 52-week high of $35.44 on 03/21/24 and a 52-week low of $26.27 on 02/28/24. A 50-day SMA is recorded $31.11, while a 200-day SMA reached $28.96. Nevertheless, trading volume fell to 0.62 million shares from 0.97 million shares the previous day.
Support And Resistance Levels for Supernus Pharmaceuticals Inc (SUPN)
According to the 24-hour chart, there is a support level at 27.26, which, if violated, would cause prices to drop to 26.74. In the upper region, resistance lies at 28.55. The next price resistance is at 29.33. RSI (Relative Strength Index) is 35.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.38, which suggests the price will decrease in the coming days. Percent R is at 95.33%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
